{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T21:33:16Z","timestamp":1770499996388,"version":"3.49.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Sleep Medicine"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1016\/j.sleep.2007.11.020","type":"journal-article","created":{"date-parts":[[2008,1,30]],"date-time":"2008-01-30T15:11:55Z","timestamp":1201705915000},"page":"715-726","source":"Crossref","is-referenced-by-count":46,"title":["Meta-analysis of the efficacy and tolerability of pramipexole versus ropinirole in the treatment of restless legs syndrome"],"prefix":"10.1016","volume":"9","author":[{"given":"S.","family":"Quilici","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.R.","family":"Abrams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Nicolas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Petit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.-L.","family":"LLeu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.W.","family":"Finnern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.sleep.2007.11.020_bib1","unstructured":"National Center on Sleep Disorders Research, National Heart Lung and Blood Institute National Institutes of Health. Restless legs syndrome: detection and management in primary care. 00-3788; 2000. NIH publication."},{"key":"10.1016\/j.sleep.2007.11.020_bib2","doi-asserted-by":"crossref","unstructured":"Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisir J. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2003;4:101\u201319.","DOI":"10.1016\/S1389-9457(03)00010-8"},{"key":"10.1016\/j.sleep.2007.11.020_bib3","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1212\/WNL.54.5.1064","article-title":"Prevalence and risk factors of RLS in an elderly population: the MEMO study. Memory and morbidity in Augsburg elderly","volume":"54","author":"Rothdach","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.sleep.2007.11.020_bib4","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1001\/archinte.165.11.1286","article-title":"Restless legs syndrome prevalence and impact, REST general population study","volume":"165","author":"Allen","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.sleep.2007.11.020_bib5","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.sleep.2004.03.006","article-title":"Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST (RLS epidemiology, symptoms, and treatment) primary care study","volume":"5","author":"Hening","year":"2004","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2007.11.020_bib6","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/00004691-200103000-00004","article-title":"Restless legs syndrome: a review of clinical and pathophysiologic features","volume":"18","author":"Allen","year":"2001","journal-title":"J Clin Neurophysiol"},{"key":"10.1016\/j.sleep.2007.11.020_bib7","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/ana.10843","article-title":"Circadian rhythm of restless legs syndrome: relationship with biological markers","volume":"55","author":"Michaud","year":"2004","journal-title":"Ann Neurol"},{"issue":"S18","key":"10.1016\/j.sleep.2007.11.020_bib8","doi-asserted-by":"crossref","first-page":"S466","DOI":"10.1002\/mds.21545","article-title":"State of the art in restless legs syndrome therapy: practice recommendations for treating restless legs syndrome","volume":"22","author":"Oertel","year":"2007","journal-title":"Mov Disord"},{"key":"10.1016\/j.sleep.2007.11.020_bib9","unstructured":"European Medicines Agency (EMEA). Available from: <www.emea.europa.eu\/>, [last accessed 20-12-2007]."},{"key":"10.1016\/j.sleep.2007.11.020_bib10","unstructured":"U.S. Food and Drug Administration (FDA). Available from: <www.fda.gov\/>, [last accessed 20-12-2007]."},{"key":"10.1016\/j.sleep.2007.11.020_bib11","unstructured":"GSK. Available from: <http:\/\/ctr.gsk.co.uk\/medicinelist.asp>, [last accessed 20-12-2007]."},{"key":"10.1016\/j.sleep.2007.11.020_bib12","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1389-9457(02)00258-7","article-title":"Validation of the international restless legs syndrome study group rating scale for restless legs syndrome","volume":"4","author":"Walters","year":"2003","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2007.11.020_bib13","unstructured":"National Institute of Mental Health. 028 CGI clinical global impressions. In: Guy W, editor. ECD-EU assessment for psychopharmacology. Rev. ed. Rockville, MD: National Institute of Mental Health; 1976. p. 217\u201322."},{"key":"10.1016\/j.sleep.2007.11.020_bib14","doi-asserted-by":"crossref","unstructured":"Whitehead A. Combining Estimates of a Treatment Difference Across Trials. Meta-Analysis of Controlled Clinical Trials. Wiley; 2003. p. 57\u201398.","DOI":"10.1002\/0470854200.ch4"},{"key":"10.1016\/j.sleep.2007.11.020_bib15","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.sleep.2007.11.020_bib16","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1002\/sim.1875","article-title":"Mixed treatment comparisons: combination of direct and indirect evidence","volume":"23","author":"Lu","year":"2004","journal-title":"Stat Med"},{"key":"10.1016\/j.sleep.2007.11.020_bib17","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1136\/bmj.331.7521.897","article-title":"Simultaneous comparison of multiple treatments: combining direct and indirect evidence","volume":"331","author":"Caldwell","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.sleep.2007.11.020_bib18","unstructured":"Spiegelhalter DJ, Thomas A, Best N, Lunn D. WinBUGS Users Manual, version 1.4.1. Cambridge: MRC Biostatistics Unit; 2004."},{"key":"10.1016\/j.sleep.2007.11.020_bib19","doi-asserted-by":"crossref","unstructured":"Spiegelhalter DJ, Abrams KR, Myles JP. Bayesian Approaches to Clinical Trials & Health-Care Evaluation. Chichester: John Wiley and Sons; 2003. ISBN: 0 71 49975 7.","DOI":"10.1002\/0470092602"},{"key":"10.1016\/j.sleep.2007.11.020_bib20","unstructured":"European Medicine Agency (EMEA). Guideline on the choice of non-inferiority margin. Available from: www.emea.europa.eu\/pdfs\/human\/ewp\/215899en.pdf; 2005 [last accessed 20-12-2007]."},{"key":"10.1016\/j.sleep.2007.11.020_bib21","unstructured":"Transparency commission. Recommendation of the commission ADARTREL. Available from: http:\/\/www.has-sante.fr\/portail\/types\/FileDocument\/cloxiti.jsp?id=c_245484; 2004 [last accessed 20-12-2007]."},{"key":"10.1016\/j.sleep.2007.11.020_bib22","unstructured":"AFSSAPS. ADARTREL, VENUXIN, ZIPEREVE 0.25mg, 0.5mg, 1mg or 2mg, comprim\u00e9 pellicul\u00e9. Rapport public d\u2019\u00e9valuation. Available from: <http:\/\/agmed.sante.gouv.fr\/htm\/5\/rappe\/rappe.htm>; 2004 [last accessed 01.10.04]."},{"key":"10.1016\/j.sleep.2007.11.020_bib23","unstructured":"Scottish Medicines Consortium. Re-submission, Ropinirol Tablets (Adartrel\u00ae). 10.2.06. Available from: http:\/\/www.scottishmedicines.org.uk\/smc\/5038.html, NHS, Scotland [last accessed 20-12-2007]."},{"key":"10.1016\/j.sleep.2007.11.020_bib24","unstructured":"Scottish Medicines Consortium. Pramipexole salt 0.125mg, 0.250mg, 1.0mg, Tablets (Mirapexin\u00ae). 10.03.06. Available from: http:\/\/www.scottishmedicines.org.uk\/smc\/4382.html, NHS, Scotland [last accessed 20-12-2007]."},{"key":"10.1016\/j.sleep.2007.11.020_bib25","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1191\/096228001678227794","article-title":"Bayesian methods in meta-analysis and evidence synthesis","volume":"10","author":"Sutton","year":"2001","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.sleep.2007.11.020_bib26","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00406-002-0380-7","article-title":"Acute placebo-controlled sleep laboratory studies and clinical follow-up with pramipexole in restless legs syndrome","volume":"252","author":"Saletu","year":"2002","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/j.sleep.2007.11.020_bib27","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1212\/WNL.52.5.938","article-title":"Restless legs syndrome improved by pramipexole: a double-blind randomized trial","volume":"52","author":"Montplaisir","year":"1999","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.sleep.2007.11.020_bib28","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1046\/j.1468-1331.2000.0070s1027.x","article-title":"Pramipexole in the treatment of restless legs syndrome: a follow-up study","volume":"7","author":"Montplaisir","year":"2000","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.sleep.2007.11.020_bib29","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.sleep.2006.03.011","article-title":"Efficacy and safety of pramipexole in idiopathic restless legs syndrome: a polysomnographic dose-finding study-The PRELUDE study","volume":"7","author":"Partinen","year":"2006","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2007.11.020_bib30","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4065\/81.1.17","article-title":"Ropinirole in the treatment of patients with restless legs syndrome: a US-based randomized, double-blind, placebo-controlled clinical trial","volume":"81","author":"Bogan","year":"2006","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.sleep.2007.11.020_bib31","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1477-7525-3-79","article-title":"The reliability, validity and responsiveness of the restless legs syndrome quality of life questionnaire (RLSQoL) in a trial population","volume":"3","author":"Abetz","year":"2005","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.sleep.2007.11.020_bib32","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.sleep.2004.12.002","article-title":"Randomized, double-blind, placebo-controlled, short-term trial of ropinirole in restless legs syndrome","volume":"6","author":"Bliwise","year":"2005","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2007.11.020_bib33","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1093\/sleep\/27.5.907","article-title":"Ropinirole decreases periodic leg movements and improves sleep parameters in patients with restless legs syndrome","volume":"27","author":"Allen","year":"2004","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2007.11.020_bib34","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1002\/mds.20257","article-title":"Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: a 12-week, double-blind, randomized, parallel-group, placebo-controlled study","volume":"19","author":"Walters","year":"2004","journal-title":"Mov Disord"},{"key":"10.1016\/j.sleep.2007.11.020_bib35","doi-asserted-by":"crossref","first-page":"747","DOI":"10.2165\/00023210-200418110-00004","article-title":"Ropinirole: for the treatment of restless legs syndrome","volume":"18","author":"Cheer","year":"2004","journal-title":"CNS Drugs"},{"key":"10.1016\/j.sleep.2007.11.020_bib36","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1212\/01.WNL.0000120672.94060.F1","article-title":"Ropinirole for restless legs syndrome: a placebo-controlled crossover trial","volume":"62","author":"Adler","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.sleep.2007.11.020_bib37","first-page":"92","article-title":"Ropinirole in the treatment of restless legs syndrome: results from the TREAT RLS 1 study, a 12 week, randomised, placebo controlled study in 10 European countries","volume":"75","author":"Trenkwalder","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.sleep.2007.11.020_bib38","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000026658","article-title":"Sleep laboratory studies in restless legs syndrome patients as compared with normals and acute effects of ropinirole. 1. Findings on objective and subjective sleep and awakening quality","volume":"41","author":"Saletu","year":"2000","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.sleep.2007.11.020_bib39","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1159\/000026659","article-title":"Sleep laboratory studies in restless legs syndrome patients as compared with normals and acute effects of ropinirole. 2. Findings on periodic leg movements, arousals and respiratory variables","volume":"41","author":"Saletu","year":"2000","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.sleep.2007.11.020_bib40","unstructured":"GlaxoSmithKline Clinical Trial Register. SKF-101468\/249 (2005), SKF-101468\/190 (2005), SKF-101468\/194 (2005), SKF-101468\/191 (2005), SKF-101468\/188 (2005), RRL100013 (2006), ROP101892 (2005) RRL100310 (2006), SKF-101468\/192 (2005), SKF-101468\/243 (2005), SKF-101468\/207 (2005), SKF-101468\/218 (2005). Available from: <http:\/\/ctr.gsk.co.uk\/Summary\/ropinirole\/studylist.asp>; 2005 [last accessed 20-12-2007]."},{"key":"10.1016\/j.sleep.2007.11.020_bib41","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1212\/01.wnl.0000231513.23919.a1","article-title":"Efficacy and safety of pramipexole in restless legs syndrome","volume":"67","author":"Winkelman","year":"2006","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.sleep.2007.11.020_bib42","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/mds.21261","article-title":"Efficacy of pramipexole in restless legs syndrome: a six-week, multicenter, randomized, double-blind study (Effect-RLS study)","volume":"22","author":"Oertel","year":"2007","journal-title":"Mov Disord"},{"key":"10.1016\/j.sleep.2007.11.020_bib43","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/mds.20983","article-title":"Controlled withdrawal of pramipexole after 6 months of open-label treatment in patients with restless legs syndrome","volume":"21","author":"Trenkwalder","year":"2006","journal-title":"Mov Disord"},{"issue":"S18","key":"10.1016\/j.sleep.2007.11.020_bib44","first-page":"S495","article-title":"Clinical trials in restless legs syndrome-Recommendations of the European RLS study group (EURLSSG)","volume":"22","author":"Trenkwalder","year":"2007","journal-title":"Mov Disord"},{"issue":"S18","key":"10.1016\/j.sleep.2007.11.020_bib45","doi-asserted-by":"crossref","first-page":"S466","DOI":"10.1002\/mds.21545","article-title":"State of the art in restless legs syndrome therapy: Practice recommendations for treating restless legs syndrome","volume":"22","author":"Oertel","year":"2007","journal-title":"Mov Disord"},{"issue":"1, Suppl. 1","key":"10.1016\/j.sleep.2007.11.020_bib46","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/j.amjmed.2006.11.004","article-title":"Current guidelines and standards of practice for restless legs syndrome","volume":"120","author":"Hening","year":"2007","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.sleep.2007.11.020_bib47","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1007\/s10072-007-0739-7","article-title":"The treatment of restless legs syndrome","volume":"28","author":"Montagna","year":"2007","journal-title":"Neurol Sci"},{"key":"10.1016\/j.sleep.2007.11.020_bib48","unstructured":"Available from: <http:\/\/www.fda.gov\/bbs\/topics\/NEWS\/2007\/NEW01596.html>, [last accessed 20-12-2007]."},{"key":"10.1016\/j.sleep.2007.11.020_bib49","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1136\/bmj.326.7387.472","article-title":"Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses","volume":"326","author":"Song","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.sleep.2007.11.020_bib50","doi-asserted-by":"crossref","first-page":"A11","DOI":"10.7326\/ACPJC-2003-138-2-A11","article-title":"Numbers needed to treat derived from meta-analysis: a word of caution","volume":"138","author":"Marx","year":"2003","journal-title":"ACP J Club"},{"key":"10.1016\/j.sleep.2007.11.020_bib51","unstructured":"Garcia-Borreguero D, Bogan R, Ritchie SY. Ninth Congress of the EFNS Athens, September 17\u201320; 2005. p. 2200."},{"key":"10.1016\/j.sleep.2007.11.020_bib52","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/1467-9868.00353","article-title":"Bayesian measures of model complexity and fit","volume":"64","author":"Spiegelhalter","year":"2002","journal-title":"J R Stat Soc Ser B"},{"key":"10.1016\/j.sleep.2007.11.020_bib53","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1198\/016214505000001302","article-title":"Assessing evidence inconsistency in mixed treatment comparisons","volume":"101","author":"Lu","year":"2006","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.sleep.2007.11.020_bib54","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1002\/sim.1403","article-title":"Approximate cross-validatory predictive checks in disease mapping models","volume":"22","author":"Marshall","year":"2003","journal-title":"Stat Med"},{"key":"10.1016\/j.sleep.2007.11.020_bib55","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1001\/archneur.61.9.1393","article-title":"Long-term treatment of restless legs syndrome with dopamine agonists","volume":"61","author":"Ondo","year":"2004","journal-title":"Arch Neurol"},{"issue":"5","key":"10.1016\/j.sleep.2007.11.020_bib56","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1191\/096228000701555244","article-title":"Modelling publication bias in meta-analysis: a review","volume":"9","author":"Sutton","year":"2000","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.sleep.2007.11.020_bib57","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"}],"container-title":["Sleep Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945707004327?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945707004327?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T20:24:51Z","timestamp":1708547091000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1389945707004327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":57,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S1389945707004327"],"URL":"https:\/\/doi.org\/10.1016\/j.sleep.2007.11.020","relation":{},"ISSN":["1389-9457"],"issn-type":[{"value":"1389-9457","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}